Karlee Pfaff, PA
Medical · Edmond, OKNPI 1992341531
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 134 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 10.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,709, more than ten times the $17 reported in 2021.
Across 134 payments — averaging $19.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$286
- Lilly USA, LLC$274
- Bayer$232
- Lundbeck LLC$190
- Pfizer$163
- Corcept Therapeutics$151
- plus $1K from 25 others
What the payments were for
- Food & beverage$2,670100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 16 | $286 |
| Lilly USA, LLC | 14 | $274 |
| Bayer | 12 | $232 |
| Lundbeck LLC | 8 | $190 |
| Pfizer | 9 | $163 |
| Corcept Therapeutics | 8 | $151 |
| Collegium Pharmaceutical, Inc. | 6 | $141 |
| Exact Sciences | 5 | $106 |
| AstraZeneca | 5 | $84 |
| Novo Nordisk | 5 | $82 |
| Axsome Therapeutics, Inc. | 3 | $81 |
| GSK | 5 | $80 |
| Johnson & Johnson | 4 | $72 |
| Noven Therapeutics, LLC | 4 | $72 |
| Mannkind Corporation | 3 | $72 |
| Teva Pharmaceuticals USA, Inc. | 3 | $66 |
| Antares Pharma, Inc. | 3 | $64 |
| Averitas Pharma Inc. | 3 | $61 |
| Organogenesis Inc. | 2 | $57 |
| Astellas Pharma US Inc | 2 | $53 |
| Smith+Nephew | 2 | $44 |
| Neos Therapeutics, LP | 2 | $40 |
| Abbott | 2 | $38 |
| IBSA Pharma Inc. | 1 | $31 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $29 |
| Seqirus USA Inc | 1 | $23 |
| Daiichi Sankyo Inc. | 1 | $23 |
| Boehringer Ingelheim | 1 | $22 |
| Eisai Inc. | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
| Genentech USA, Inc. | 1 | $5 |
How this compares
$2,670 in reported general payments places this provider in the 80th percentile of 370 medical providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 16 | $168 |
| Ciprofloxacin Hcl | 17 | $75 |
| Methylprednisolone | 11 | $63 |
| Prednisone | 14 | $36 |
| Azithromycin | 13 | $23 |
Paid to pharmacies, not to this prescriber.
Other medical in Edmond
- Elizabeth MontgomeryEdmond$9K
- Amelia MonchoEdmond$7K
- Amber WellmanEdmond$5K
- Crystal FredricksonEdmond$5K
- Bethany TrianaEdmond$4K
- Shannon MedleyEdmond$3K
- Mebin ThomasOklahoma City$323K
- Kelle ChristiansonMidwest City$117K
- Kristine MurrowOklahoma City$81K
- Matthew DohlmanTulsa$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.